Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)GlobeNewsWire • 08/19/21
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/17/21
Rockwell Medical (RMTI) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/16/21
Rockwell Medical, Inc. Provides Second Quarter 2021 Financial and Operational UpdateGlobeNewsWire • 08/16/21
Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home InfusionGlobeNewsWire • 06/28/21
Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic® in TurkeyGlobeNewsWire • 06/08/21
Rockwell Medical's (RMTI) CEO Russell Ellison on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/17/21
Rockwell Medical, Inc. Provides First Quarter 2021 Financial and Operational UpdateGlobeNewsWire • 05/17/21
Rockwell Medical Presents Data on Diagnosis and Management of Iron Deficiency Anemia in Home Parenteral Nutrition Patients at the NHIA 2021 Annual ConferenceGlobeNewsWire • 04/22/21
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/01/21
Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational UpdateGlobeNewsWire • 03/31/21
Do Options Traders Know Something About Rockwell Medical (RMTI) Stock We Don't?Zacks Investment Research • 03/17/21
Will Rockwell Medical (RMTI) Report Negative Q4 Earnings? What You Should KnowZacks Investment Research • 03/04/21
Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on HemodialysisGlobeNewsWire • 02/09/21
Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.GlobeNewsWire • 02/01/21
Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in ChinaGlobeNewsWire • 01/13/21
Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2021 ConferenceGlobeNewsWire • 01/05/21